ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0551

Clustering Trajectories of eGFR Using Latent Process Mixed Models and Unsupervised Learning

Session Information

Category: Genetic Diseases of the Kidneys

  • 1201 Genetic Diseases of the Kidneys: Monogenic Kidney Diseases

Authors

  • Zhang, Zhen, Otsuka America Pharmaceutical Inc, Princeton, New Jersey, United States
  • Yu, Kunbo, Pharmapace, Inc., San Diego, California, United States
  • Jiang, Huan, Otsuka America Pharmaceutical Inc, Princeton, New Jersey, United States
Background

Characterizing long-term kidney function trajectories is essential to identify distinct progression patterns in patients with autosomal dominant polycystic kidney disease (ADPKD). While Mayo Imaging Classification provides early stratification, trajectory-based approaches may uncover additional patient heterogeneity. This study aimed to apply latent process mixed models and unsupervised learning to identify distinct estimated Glomerular Filtration Rate (eGFR) trajectory clusters using real-world longitudinal data.

Methods

Using longitudinal eGFR data from a subgroup of patients in the OVERTURE study (NCT01430494) with baseline Mayo Imaging Classification, latent class mixed models (LCMM) with linear, quadratic, and cubic trends were fitted to identify trajectory clusters, considering duration as the true time scale. The optimal number of clusters was selected based on AIC. Additionally, a two-stage unsupervised learning approach was conducted: local regression models were fitted per patient, and K-means clustering was applied to the extracted coefficients. Clustering solutions from LCMM and unsupervised learning were compared by cross-tabulation and adjusted Rand Index.

Results

Among 2990 patients with sufficient longitudinal eGFR data, LCMM identified six distinct trajectory classes ranging from early rapid decliners, moderate progressors, to slow progressors, which aligned partially but not completely with Mayo Classes. K-means clustering on local regression model coefficients suggested similar patterns but with moderate concordance (adjusted Rand Index = 0.3) to LCMM. Patients in the slow-declining class had lower baseline height-adjusted TKV, younger age and favored vital signs at baseline. LCMM and unsupervised learning results reduced within-cluster sum of squares (WCSS) under Mayo classification by 61% and 37%, respectively. The clustering approaches provided complementary perspectives for patient stratification.

Conclusion

Trajectory-based clustering using LCMM and unsupervised learning methods offers a data-driven approach to enrich ADPKD patient characterization and may inform future risk stratification strategies beyond traditional imaging classifications.

Funding

  • Commercial Support – Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ

Digital Object Identifier (DOI)